Dysmenorrhoea: features and current treatment options
نویسندگان
چکیده
منابع مشابه
Hand dermatitis: current treatment options.
Avoidance advice: This forms a very important component of treatment once a diagnosis of contact dermatitis has been made on the basis of a detailed history, examination and patch testing. Possible sources of exposure to the causative allergens should be identified and advice has to be tailored to an individual. The patient should be informed about the identification of the offending agent and ...
متن کاملthe current diagnostic and treatment options for managing hemobilia
hemobilia is a rare source of upper gasterointestinal bleeding. though the incidence is increasing along with the rise in minimally invasive biliary interventions. prompt diagnosis and treatment rests of having appropriate clinical suspicion which should be based on the patients presenting signs and symptoms, as well as history including recent instrumentation. endoscopy should be reservedfor c...
متن کاملSubclinical hyperthyroidism: clinical features and treatment options.
Subclinical hyperthyroidism appears to be a common disorder. It may be caused by exogenous or endogenous factors: excessive TSH suppressive therapy with L-thyroxine (L-T4) for benign thyroid nodular disease, differentiated thyroid cancer, or hormone over-replacement in patients with hypothyroidism are the most frequent causes. Consistent evidence indicates that 'subclinical' hyperthyroidism red...
متن کاملNarcolepsy: current treatment options and future approaches
The management of narcolepsy is presently at a turning point. Three main avenues are considered in this review: 1) Two tendencies characterize the conventional treatment of narcolepsy. Modafinil has replaced methylphenidate and amphetamine as the first-line treatment of excessive daytime sleepiness (EDS) and sleep attacks, based on randomized, double blind, placebo-controlled clinical trials of...
متن کاملCurrent and future treatment options for HCV.
Aim of antiviral therapy of patients with chronic hepatitis C is the sustained elimination of the hepatitis C virus (HCV). The standard of care (SOC) is peginterferon alfa-2a/-2b with ribavirin for 48 weeks or 24 weeks in patients infected with HCV genotype 1 or 2/3, respectively. Overall, approximately half of the patients can be cured by SOC. Based on baseline viral load and the speed of viro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Prescriber
سال: 2006
ISSN: 0959-6682,1931-2253
DOI: 10.1002/psb.397